Seeing Is Believing
NRIX is currently covered by 11 analysts with an average price target of $27.07. This is a potential upside of $14.29 (111.82%) from yesterday's end of day stock price of $12.78.
Nurix Therapeutics 's activity chart (see below) currently has 36 price targets and 64 ratings on display. The stock rating distribution of NRIX is 88.1% BUY and 11.9% HOLD.
Analysts average stock forecasts to be materialized ratio is 18.04% with an average time for these price targets to be met of 17.57 days.
Highest price target for NRIX is $31, Lowest price target is $10, average price target is $27.07.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 11-Apr-2024. First documented stock forecast 18-Aug-2020.
Currently out of the existing stock ratings of NRIX, 37 are a BUY (88.1%), 5 are a HOLD (11.9%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$12.27 (96.39%)
24
22 days ago
0/6 (0%)
$7.79 (45.26%)
Buy
31
$18.27 (143.52%)
31
22 days ago
0/14 (0%)
$13.79 (80.13%)
Buy
23
$10.27 (80.68%)
22
22 days ago
0/7 (0%)
$5.79 (33.64%)
Hold
10
$-2.73 (-21.45%)
12
2 months 7 days ago
2/3 (66.67%)
$-1.15 (-10.31%)
114
Buy
19
$6.27 (49.25%)
35
2 months 13 days ago
0/8 (0%)
$8.91 (88.31%)
What is NRIX (Nurix Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on NRIX (Nurix Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on NRIX (Nurix Therapeutics )?
Which analyst is the currently most bullish on NRIX (Nurix Therapeutics )?
Which analyst is the currently most reserved on NRIX (Nurix Therapeutics )?